Oral Supplementation During PR Participation in COPD

PHASE2RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 11, 2024

Primary Completion Date

March 4, 2025

Study Completion Date

May 31, 2025

Conditions
Copd
Interventions
DIETARY_SUPPLEMENT

Urolithin A (Mitopure)

Compound belonging to the 'urolithin' class. First discovered over 40 years ago as a gut-derived metabolite in rats and subsequently in humans. A food and dietary ingredient, and more specifically, a post-biotic compound. Derived from ellagitannins, which are present in foods such as pomegranate, berries, and walnuts. An 'inducer' of mitophagy.

OTHER

Placebo

Placebo.

Trial Locations (1)

H4A 3J1

RECRUITING

McGill University Health Centre, Montreal

All Listed Sponsors
collaborator

Amazentis SA

INDUSTRY

lead

McGill University Health Centre/Research Institute of the McGill University Health Centre

OTHER